the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis

Summary

This is a randomized, controlled study evaluating diosmin tablets administered daily for 3 months. The purpose of the study is to evaluate the efficacy and safety of diosmin in the treatment of mild to moderately active ulcerative colitis. Disease activity will be measured using modified truelove and witt's classification.

Timeline

Start

2022-12-15

Primary completion

2023-11

Completion

2024-11

Drugs

Indications